Industry Explorers Blaze On

  1. Corporate Social Responsibility: Action Builds Community 9/1/2023

    Despite the hand-wringing that often accompanies conversations around corporate social responsibility (CSR), there is nothing controversial about basic human needs.

  2. Strategic Business Pivoting For Cell & Gene Startups 9/1/2023

    Understanding the different types of pivots and when to use them can increase the chances of success for any life sciences company.

  3. Addressing The Uncertainties Of The IRA In Biopharma 9/1/2023

    In recent years, the biopharma industry has been anything but predictable. But the creation of the Inflation Reduction Act (IRA) of 2022 has added a new layer of uncertainty that reaches most corners of the industry.

  4. The DEI Value Proposition 9/1/2023

    The value of DEI initiatives sometimes get lost in their feel-good, altruistic intent. Not at Rocket Pharmaceuticals, where purposeful and specific equity and inclusion exercises pay dividends in the form of a diverse, talented, and committed workforce. President & COO Kinnari Patel, PharmD explains.

  5. 3 Traits For Compliance Execs To Become Business Leaders 9/1/2023

    Evaluating a wider range of inputs and forming your own strategic viewpoint aligned with business priorities enables you to pivot to being a business leader, rather than an advisor to business leaders.

  6. To America, A New Biopharma Model 9/1/2023

    Ketan Mehta, founder and CEO of Tris Pharma. Mehta came to the U.S. in the late 1970s. Since then, he has built a career in pharma and, more recently, an entirely new company with a triad of businesses — platform technology licensing, generic medicines, and new drug development.

  7. How Can Executives Work Through Tightened Budgets And Manage Tradeoffs While Keeping The Workforce Happy And Motivated? 9/1/2023

    See the answer from Tim Wright, chairman of the board of directors at Isosceles Pharmaceuticals.

  8. Biotech Veteran Pushes New Science And Regulatory Change 9/1/2023

    Ashvattha Therapeutics CEO Jeff Cleland hopes to bring hydroxyl dendrimer therapeutics to market for the first time, while also pushing for policy and regulatory change as an advocate for BIO.

  9. How Program Managers Can Help Reach Development Milestones 9/1/2023

    Though commonly misunderstood, the program manager fuses the varied projects within the larger program and strategically places them into an integrated development plan so companies can successfully reach (and announce via press releases) each milestone while preparing for the next.

  10. How To Make The RTO More Productive For Employees 9/1/2023

    As workers return to the office, the workplace will need to be tailored to better support their needs. Some of the considerations — from flexible hybrid options to new kinds of office environments — may inspire more employees to come back in person.